Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...

But dysgraphia goes beyond just handwriting — it can also affect a child’s ability to express thoughts in writing, which in turn can impact their academic performance and, in many cases, their ...

The study aimed to determine whether treatment with high dose ocrelizumab would provide an additional benefit in slowing disability progression.

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

Relapsing-remitting multiple sclerosis (RRMS) is a type of MS characterized by periods of neurologic symptoms and periods of remission. Learn more.

Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) ...

WebMD explains the symptoms and treatment of relapsing-remitting multiple sclerosis, the most common of the four types of MS.

Top-line results of a phase 2 clinical trial for an adiposederived autologous mesenchymal stem cell therapy to address mild to moderate relapsing-remitting MS found the treatment improved mental ...

Secondary Progressive MS Many people who receive an initial diagnosis of relapsing-remitting MS gradually worsen over time, separate from exacerbations.

"The observation that progression can occur without preceding relapse in early relapsing remitting MS patients now has been replicated in multiple cohorts and is recognized as the most common ...

After undergoing tests, she received her diagnosis: relapsing-remitting multiple sclerosis, the most common form, in which symptoms can flare up and dissipate.